ClickHouse Extends Series C Financing and Expands Leadership Team to Fuel Growth
7.10.2025 15:00:00 CEST | Business Wire | Press release
ClickHouse, a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced an extension of its Series C financing and related transactions. New investors Citi Ventures, Insight Partners, Peak XV Partners, Founders Circle Capital, D. E. Shaw Ventures, Adams Street Partners, Rosberg Ventures, Expanding Capital, and notable individuals such as 49ers Brock Purdy, Christian McCaffrey, and Kyle Juszczyk joined the round, with continued participation from existing investors Altimeter, Bessemer Venture Partners, IVP, BOND, and GIC.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007292299/en/

ClickHouse co-founders (from left to right): Yury Izrailevsky, Aaron Katz, Alexey Milovidov
The company has surpassed 2,000 customers and more than quadrupled ARR over the past year. Customer adoption has surged, with new wins including Cyera, Hewlett Packard Enterprise, Insider, Laravel, Masorange, Qualified, Shopmonkey, and Supabase, while long-term customers such as Canva, Harvey, LangChain, Perion, and SonyLIV extended their contracts. Adoption has been especially strong among AI companies, with Anthropic, LangChain, Meta, Sierra, Vercel, and Weights & Biases joining the roster of companies running business-critical systems on ClickHouse Cloud.
Recognition of the company’s momentum has also continued to grow. ClickHouse was named to the 2025 Forbes Cloud 100 list, underscoring its position as one of the most innovative and fast-growing private cloud companies. The company hosted its inaugural user conference, OpenHouse, which brought together customers and partners, including OpenAI, Anthropic, and Tesla. The event featured keynote presentations, product demonstrations, and customer success stories, highlighting how ClickHouse is powering AI and analytics initiatives across industries. Building on that energy, ClickHouse will once again host its AWS re:Invent party, “HouseParty, the SQL,” headlined by The Chainsmokers.
The company bolstered its leadership team with three key hires. In July, Kevin Egan joined as Chief Revenue Officer, bringing more than two decades of enterprise sales leadership with senior roles at Atlassian, Slack, Dropbox, and Salesforce. In August, Mariah Nagy came on board as Vice President of People, bringing deep experience leading people teams at high-growth companies including Weights & Biases, Confluent, and SurveyMonkey. Most recently, Jimmy Sexton joined as Chief Financial Officer, bringing extensive finance leadership experience from Snowflake and ServiceNow.
ClickHouse continues to advance its platform across multiple use cases:
- The company launched ClickStack, a high-performance observability stack that unifies logs, metrics, traces, and session replays into a single platform.
- For real-time analytics workloads, ClickHouse added MongoDB Change Data Capture (CDC), enabling seamless integration of MongoDB data streams with ClickHouse for analytics.
- For data warehousing, enhancements to data lake support improve read and write operations and optimize performance for Iceberg and Delta Lake.
- To enable building agent-facing applications, ClickHouse introduced the MCP Server endpoint and AskAI Assistant in ClickHouse Cloud, giving developers and teams the tools to quickly deploy intelligent, interactive AI-driven experiences on top of ClickHouse data.
- Across all these use cases, the database continues to evolve with improvements in vector search, JSON support, and full-text search.
- Recognizing the needs of regulated environments, ClickHouse announced ClickHouse Private, a private cloud version of its commercial offering, with ClickHouse Government adding FIPS compliance for the most highly regulated environments.
“We are incredibly grateful for the continued confidence and support from our investors,” said Aaron Katz, CEO of ClickHouse. “This extended Series C financing will accelerate our mission to empower organizations with lightning-fast analytics on massive datasets. Our data platform gives customers the speed, flexibility, and efficiency they need to tackle their most critical use cases at scale, helping them unlock value faster in the era of AI.”
“ClickHouse is transforming how companies use data,” said Vibhor Rastogi, head of AI investing at Citi Ventures. “The demand for fast, interactive analytics has never been greater, especially as data-driven AI initiatives accelerate. We believe ClickHouse is uniquely positioned to lead this market, and we’re excited to support the team as they continue scaling their platform, expanding their product capabilities, and helping customers unlock new value from their data.”
“Analytics is at the core of our products,” said Yotam Segev, Co-Founder & CEO at Cyera. “ClickHouse Cloud gives us the speed and scale to analyze massive volumes of security data directly within our platform. That foundation not only strengthens our customers’ ability to manage and reduce risk today, but also enables us to power new AI-driven capabilities that make threat prevention, detection, and response faster and more effective.”
About ClickHouse
ClickHouse is a fast, open-source columnar database management system built for real-time data processing and analytics at scale. Engineered for high performance, ClickHouse Cloud delivers exceptional query speed and concurrency, making it ideal for applications that demand instant insight from massive volumes of data. As AI agents become increasingly embedded in software and are generating far more frequent and complex queries, ClickHouse brings a high-throughput, low-latency engine, purpose-built to meet this challenge. Trusted by leading companies like Sony, Tesla, Anthropic, Memorial Sloan Kettering, Lyft, and Instacart, ClickHouse helps teams unlock insights and drive smarter decisions with a scalable, efficient, and modern data platform. For more information, visit clickhouse.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251007292299/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom